- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chiome Bioscience Inc (4583)
Chiome Bioscience Inc stock price live, this page displays TYO 4583 stock exchange data. View the 4583 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chiome Bioscience Inc real time stock price chart below.
What Is the Chiome Bioscience Inc Stock Price Today?
The Chiome Bioscience Inc stock price today is 119.0.
What Is the Stock Symbol for Chiome Bioscience Inc?
The stock symbol for Chiome Bioscience Inc is "4583."
What Stock Exchange Does Chiome Bioscience Inc Trade On?
Chiome Bioscience Inc is listed and trades on the Tokyo stock exchange.
Is Chiome Bioscience Inc a Good Stock to Buy?
Determining whether Chiome Bioscience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4583 quote. (ISIN: JP3205350006)
What Is the Chiome Bioscience Inc Stock Price Today?
The Chiome Bioscience Inc stock price today is 119.0.
What Is the Stock Symbol for Chiome Bioscience Inc?
The stock symbol for Chiome Bioscience Inc is "4583."
What Stock Exchange Does Chiome Bioscience Inc Trade On?
Chiome Bioscience Inc is listed and trades on the Tokyo stock exchange.
Is Chiome Bioscience Inc a Good Stock to Buy?
Determining whether Chiome Bioscience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4583 quote. (ISIN: JP3205350006)
Tokyo
Currency in JPY
119.0
+7.0(+6.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
111.0
119.0
52 wk Range
105.0
265.0
4583 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
111.0119.0
52 wk Range
105.0265.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4583 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Chiome Bioscience Inc Company Profile
Chiome Bioscience Inc. engages in the research and development of drug discovery technology platforms worldwide. It operates in two segments, Drug Discovery Business and Drug Discovery Support Business. The company offers ADLib System, a technology for generating monoclonal antibodies which is used to generate antibodies for drug discovery research; and Human ADLib System, which converts chicken antibody genes to humanized antibodies. It also provides protein expression and purification services; stable cell line development services for recombinant protein and antibody production; and antibody generation services using the ADLib system. In addition, the company’s product pipeline under Phase 1 trial comprises ADCT-701, an anti-dlk1 antibody for treating liver cancer; CBA-1205, an afucosylated anti-dlk1 antibody for liver cancer, lung cancer, and neuroblastoma; and CBA-1535, an anti 5T4/WAIF1 antibody for malignant mesothelioma, small cell lung cancer, non-small cell lung cancer, and triple negative breast cancer (TNBC). Further, its product pipeline under preclinical study includes PCDC, an anti- CDCP1 antibody for lung, colorectal, pancreatic, breast, and ovarian tumors; PTRY, an antibody 5T4/CD3/PD-L1 for treating malignant mesothelioma, small cell lung cancer, non-small cell lung cancer, and TNBC; BMAA, an anti-semphorin3a antibody for treating renal and other diseases; LIV-2008/2008b, an anti-TROP-2 antibody for the treatment of TNBC, lung cancer, and colorectal cancer; PFKR, an anti-CX3CR1 antibody for secondary progressive multiple sclerosis; and PXLR, an anti-CXCL1/2/3/5 antibody for the treatment of gastric, breast, and ovarian tumors. Chiome Bioscience Inc. was incorporated in 2005 and is headquartered in Tokyo, Japan.
Compare 4583 to Peers and Sector
Metrics to compare | 4583 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4583PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.9x | −4.2x | −0.6x | |
PEG Ratio | −0.17 | −0.01 | 0.00 | |
Price/Book | 6.5x | 1.3x | 2.6x | |
Price / LTM Sales | 11.1x | 2.1x | 3.4x | |
Upside (Analyst Target) | - | 49.6% | 41.1% | |
Fair Value Upside | Unlock | 6.9% | 5.3% | Unlock |
Earnings
Latest Release
Nov 11, 2025
EPS / Forecast
-3.82 / --
Revenue / Forecast
118.00M / --
FAQ
What Is the Chiome Bioscience (4583) Stock Price Today?
The Chiome Bioscience stock price today is 119.0
What Stock Exchange Does Chiome Bioscience Trade On?
Chiome Bioscience is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Chiome Bioscience?
The stock symbol for Chiome Bioscience is "4583."
What Is the Chiome Bioscience Market Cap?
As of today, Chiome Bioscience market cap is 8.10B.
What Is Chiome Bioscience's Earnings Per Share (TTM)?
The Chiome Bioscience EPS (TTM) is -13.54.
When Is the Next Chiome Bioscience Earnings Date?
Chiome Bioscience will release its next earnings report on Feb 09, 2026.
From a Technical Analysis Perspective, Is 4583 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Chiome Bioscience Stock Split?
Chiome Bioscience has split 3 times.
How Many Employees Does Chiome Bioscience Have?
Chiome Bioscience has 53 employees.
What is the current trading status of Chiome Bioscience (4583)?
As of Jan 17, 2026, Chiome Bioscience (4583) is trading at a price of 119.0, with a previous close of 112.0. The stock has fluctuated within a day range of 111.0 to 119.0, while its 52-week range spans from 105.0 to 265.0.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.